VAERS Explorer
Back to explore

Report #2892822

Received Apr 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
IL
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPIPVHIBDTAP + IPV + HIB (PENTACEL)SANOFI PASTEURUNKUK370AA

Symptoms (1)

Product preparation issue

Symptom narrative

pentacel was adminstered without the hib component, pentacel not mixed and only the liquid dtap was given with no reported adverse event; Initial information received on 27-Mar-2026 regarding an unsolicited valid non-serious case received from a nurse. This case involves an unknown age patient of unknown gender who was administered Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] without the hib component, and only the liquid dtap was given with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), family history were not provided. On unknown date, the patient received an unknown dose of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine, Powder and suspension for suspension for injection of unknown strength (batch: UK370AA, expiration date: 31-Mar-2027) via unknown route in an unknown administration site for immunization, without the Hib component, and only the liquid dtap was given with no reported adverse event [Single component of a two-component product administered] (Latency: Same day). Action taken: Not reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.